Thymosin β 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoids

Nature Medicine

Volumn 5, Issue 12, 1999, Pages 1424-1427

  Young, J D ^a   Lawrence, A J ^a   Maclean, A G ^b   Leung, B P ^a   Mcinnes, I B ^c   Canas, B ^d   Pappin, D J C ^d   Stevenson, R D ^c  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b HARVARD MEDICAL SCHOOL   (United States)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

^d IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; GLUCOCORTICOID; SULFOXIDE; THYMOSIN BETA4;

ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; HUMAN; HUMAN CELL; IMMUNOREGULATION; INFLAMMATION; INFLAMMATORY DISEASE; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARRAGEENAN; CATTLE; CHEMOTAXIS, LEUKOCYTE; EDEMA; GLUCOCORTICOIDS; HUMANS; METHIONINE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MONOCYTES; NEUTROPHILS; OXIDATION-REDUCTION; THYMOSIN;

EID: 0032735680     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/71002     Document Type: Article

References (25)

1. Cato, C.B. & Wade, M.E. Molecular mechanisms of anti-inflammatory action of glucocorticoids. Bioessays 18, 371-378 (1996).
2. Abbinante-Nissen, J.M., Simpson, L.G. & Leikauf, G.D. Corticosteroids increase secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am. J. Physiol. 268, 601-606 (1995).
3. Stevenson, R.D. Mechanism of anti-inflammatory action of glucocorticosteroids. Lancet i, 225-226 (1977).
4. Stevenson, R.D. Studies on the production and action of polymorph migration stimulator Clin. Exp Immunol. 24, 527-533 (1976).
5. Chettibi, S., Lawrence, A.J., Young, J.D. & Stevenson, R.D., Dispersive locomotion of human neutrophils in response to a steroid-induced factor from monocytes. J. Cell Sci. 107, 3173-3181 (1994).
6. Young, J.D., MacLean, A.G., Lawrence, A.J., Stevenson, R.D. & Chettibi, S. Relationship of human neutrophil morphology and actin distribution to dispersive locomotion caused by a steroid-induced factor. Exp. Biol. Online 2, 7 (1997).
7. Heintz, D. etl al. The sulfoxide of thymosin beta-4 almost lacks the polymerization-inhibiting capacity for actin. Eur. J. Biochem. 223, 345-350 (1994).
8. Jeffrey, C.J. Moonlighting proteins. Trends Biochem. Sci. 24 8-11 (1999).
9. Sherman, N.E. et al. in Proc. 43rd ASMS Conf. Mass Spectrom. Allied Top. 626-627 (Atlanta, Georgia, 21-26 May, 1995).
10. Thurman, G.R., Seals, C., Low, T.L.K. & Goldstein, A.L. Restorative effects of thymosin polypeptides on purified protein derivative-dependent migration inhibition factor production by the peripheral blood lymphocytes of adult thymectomized guinea pigs. J. Biol. Resp. Mod. 3, 160-173 (1984).
11. Cassimeris, L., Safer, D., Nachmias, V.T. & Zigmond, S.H. Thymosin β4 sequesters the majority of G-actin in resting human polymorphonuclear leukocytes. J. Cell Biol. 119, 1261-1270 (1992).
12. Malinda, K.M., Goldstein, A.L. & Kleinman, H.M. Thymosin β4 stimulates directional migration of human umbilical vein endothelial cells. FASEB J. 11, 472-481 (1997).
13. Ianaro, A., O'Donnell, C.A., Di Rosa, M., & Liew, F.Y. A nitric oxide synthase inhibitor reduces inflammation, downregulates inflammatory cytokines and enhances interleukin-10 production in carrageenan induced oedema in mice. Immunology 82, 370-375 (1994).
14. Nachmias, V.T. Small actin-binding proteins: the β-thymosin family. Curr. Opin. Cell Biol. 5, 56-62 (1993).
15. Feinberg, J., Hertz, F., Benjamin, V. & Roustan, C. The N-terminal sequence (5-20) of thymosin β4 binds to monomeric actin in an α-helical conformation. Biochem. Biophys. Res. Comm. 222, 127-132 (1996).
16. Watson, A.A., Fairlie, D.P. & Craik, D.J. Solution structure of methionine-oxidized amyloid beta-peptide (1-40). Does oxidation affect conformational switching? Biochemistry 17, 12700-12706 (1998).
17. Swaim M.W. & Pizzo S.V. Methionine sulphoxide and the oxidative regulation of plasma proteinase inhibitors. J. Leuk. Biol. 43, 365-379 (1988).
18. Vogt, W. Oxidation of methionyl residues in proteins: tools, targets, and reversal. Free Radic. Biol. Med 18, 93-105 (1995).
19. Levine, R. L., Mosoni, L., Berlett, B.S. & Stadtman, E.R. Methionine residues as endogenous antioxidants in proteins. Proc. Nat. Acad. Sci. USA 93, 15036-15040 (1996).
20. Beck-Speier I., Leuschel L., Luippold G. & Maier K. L. Proteins released from human neutrophils contain very high levels of oxidized methionine. FEBS Lett. 227, 1-4, (1988).
21. Fliss H., Weissbach H. & Brot N Oxidation of methionine residues in proteins of activated human neutrophils. Proc. Natl. Acad. Sci. USA 80, 7160-7164 (1983).
22. Ciorba, M.A., Heinemann, S.H., Weissbach, H., Brot, N. & Hoshi, T. Modulation of potassium channel function by methionine oxidation and reduction. Proc. Natl. Acad. Sci. USA 94, 9932-9937 (1997).
23. Moskovitz, J. et al. Overexpression of peptide-methionine sulfoxide reductase in Saccharomyces cerevisiae and human T cells provides them with high resistance to oxidative stress. Proc. Natl. Acad. Sci. USA 95, 14071-14075 (1998).
24. Vogt, W., Zimmermann, B., Hesse, D & Nolte, R. Activation of the fifth component of the human complement, C5, without cleavage, by methionine oxidising agents. Mol. Immunol. 29, 251-256 (1992).
25. Hannappel, E. & van Kampen, M. Determination of thymosin β4 in human blood cells and serum. J. Chromat. 397, 279-285 (1987).